ESR1 and breast carcinoma: E2 mainly exerts its effect through the classical genomic pathway involving estrogen receptors alpha (ERα) and beta (ERβ) that function as transcription factors [4], with ERα being essential for proliferative signaling in both normal and breast cancer cells [5].